SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Cooney DA, Rosenbluth RJ. Enzymes as therapeutic agents. Adv Pharmacol. 1975; 12: 19851962.
  • 2
    Asselin BL. The three asparaginases. Comparative pharmacology and optimal use in childhood leukemia. Adv Exp Med Biol. 1999; 457: 621629.
  • 3
    Müller HJ, Boos J. Use of L-asparaginase in childhood ALL. Crit Rev Oncol/Hematol. 1998; 28: 97113.
  • 4
    Rogers QR. Species variation in arginine requirements. Proceedings from a symposium honoring Willard J. Visek—from ammonia to cancer and gene expression. Special Publication 86, Agriculture Experiment Station, University of Illinois, April 4–5, 1994: 921.
  • 5
    Barbul A. Arginine: biochemistry, physiology, and therapeutic implications. J Parenteral Enteral Nutr. 1986; 10: 227238.
  • 6
    Tycell E, Neuman RE. Growth response of stable and primary cell cultures to L-ornithine and L-citrulline and L-arginine. Exp Cell Res. 1960; 20: 8491.
  • 7
    Kenny GE, Pollock ME. Mammalian cell cultures contaminated with pleuropneumonia-like organisms. I. Effect of pleuropneumonia-like organisms on growth of established cell strains. J Infect Dis. 1963; 112: 716.
  • 8
    Kraemer PM, Defendi V, Hayflick L, Manson LAl. Mycoplasma (PPLO) strains with lytic activity for murine lymphoma cells in vitro. Proc Soc Exp Biol Med. 1963; 112: 381387.
  • 9
    Kraemer PM. Interaction of Mcyoplasmad (PPLO) and murine lymphoma cell cultures: prevention of cell lysis by arginine. Proc Soc Exp Biol Med. 1964; 115: 206212.
  • 10
    Schimke RT, Berlin CM, Sweeney EW, Carroll WRI. The generation of energy by the arginine dihydrolase pathway in Mycoplasma hominis 07. J Biol Chem. 1964; 241: 22282236.
  • 11
    Sugimura K, Ohno T, Fukuda S, Wada Y, Kimura T, Azuma I. Tumor growth inhibitory activity of a lymphocyte blastogenesis inhibitory factor. Cancer Res. 1990; 50: 345349.
  • 12
    Ensor CM, Holtsberg FW, Bomalaski JS, Clark MA. Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo. Cancer Res. 2002; 62: 54435450.
  • 13
    Sugimura K, Ohno T, Kusuyama T, Azuma I. High sensitivity of human melanoma cell lines to the growth inhibitory activity of Mcyoplasmadl arginine deiminase in vitro. Melanoma Res. 1992; 2: 191196.
  • 14
    Kobayashi SN, Terazono H, Fukushige T, Horiuchi M, Saheki T. Characterization of human wild type and mutant argininosuccinate synthase proteins expressed in bacterial cells. Enz Protein. 1994; 48: 251264.
  • 15
    Gilroy E. The influence of arginine upon the growth rate of a transplantable tumour in the mouse. Biochem J. 1930; 24: 589595.
  • 16
    Yeatman TJ, Risley GL, Brunson ME. Depletion of dietary arginine inhibits growth of metastatic tumor. Arch Surg. 1991; 126: 13761382.
  • 17
    Gonzalez GG, Byus CV. Effect of dietary arginine restriction upon ornithine and polyamine metabolism during two-stage epidermal carcinogenesis in the mouse. Cancer Res. 1991; 51: 29322939.
  • 18
    Simberkoff MS, Thorbecke GJ, Thomas L. Studies on PPLO infection. V. Inhibition of lymphocyte mitosis and antibody formation by Mcyoplasmadl extracts. J Exp Med. 1969; 129: 11631181.
  • 19
    Sun NC, Sun CRY, Tennant RW, Hsie AW. Selective growth of some rodent epithelial cells in medium containing citrulline. Proc Natl Acad Sci USA. 1979; 76: 18191823.
  • 20
    Miyazaki K, Takaku H, Umeda M, et al. Potent growth inhibition of human tumor cells in culture by arginine deiminase purified from a culture medium of a Mycoplasma-infected cell line. Cancer Res. 1990; 50: 45224527.
  • 21
    Takaku H, Takase M, Abe S-I, Hayashi H, Miyazaki K. In vivo anti-tumor activity of arginine deiminase purified from Mycoplasma arginini. Int J Cancer. 1992; 51: 244249.
  • 22
    Takaku H, Misawa S, Hayashi H, Miyazaki K. Chemical modification by polyethylene glycol of the anti-tumor enzyme arginine deiminase from Mycoplasma arginini. Jpn J Cancer Res. 1993; 84: 11951200.
  • 23
    Moyer GH, Pitot HC. Static and dynamic aspects of amino acid pools in rat liver and Morris hepatomas 9618A and 7800. Cancer Res. 1974; 334: 26472653.
  • 24
    Scott L, Lamb J, Wheatley DN. Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells. Br J Cancer. 2000; 83: 800810.
  • 25
    Takaku H, Matsumoto M, Misawa S, Miyazaki M. Anti-tumor activity of arginine deiminase from Mycoplasma arginini and its growth-inhibitory mechanism. Jpn J Cancer Res. 1995; 86: 840846.
  • 26
    Holtsberg FW, Ensor CM, Steiner MR, Bomalaski JS, Clark MA. Poly(ethylene glycol) (PEG) conjugated arginine deiminase: effects of PEG formulations on its pharmacological properties. J Control Rel. 2002; 80: 259271.
  • 27
    Thomas JB, Holtsberg FW, Ensor CM, Bomalaski JS, Clark MA. Enzymatic degradation of plasma arginine using arginine deiminase inhibits nitric oxide production and protects mice from the lethal effects of tumour necrosis factor α and endotoxin. Biochem J. 2002; 363: 581587.
  • 28
    Dillon BJ, Holtsberg FW, Ensor CM, Bomalaski JS, Clark MA. Biochemical characterization of the arginine degrading enzymes arginase and arginine deiminase and their effect on nitric oxide production. Med Sci Monit. 2002; 8: 248253.
  • 29
    Shi MM, Bleavins MR, Iglesia FA. Pharmacogenetic application in drug development and clinical trials. Drug Met Disp. 2001; 29: 591595.
  • 30
    Gill P, Pan J. Inhibition of cell division in L5178Y cells by arginine-degrading Mcyoplasmads: the role of arginine deiminase. Can J Microbiol. 1970; 16: 415419.
  • 31
    Gong H, Zölzer F, von Recklinghausen G, et al. Arginine deiminase inhibits cell proliferation by arresting cell cycle and inducing apoptosis. Biochem Biophys Res Commun. 1999; 261: 1014.
  • 32
    Gong H, Zölzer F, von Recklinghausen G, Havers W, Schweigerer L. Arginine deiminase inhibits proliferation of human leukemia cells more potently than asparaginase by inducing cell cycle arrest and apoptosis. Leukemia. 2000; 14: 826829.
  • 33
    Jones JB. The effect of arginine deiminase on murine leukemia lymphoblasts [Ph.D. dissertation]. Oklahoma City, OK: University of Oklahoma, 1981: 1169.
  • 34
    Misawa S, Aoshima M, Takaku H, Matsomoto M, Hayashi H. High-level expression of Mycoplasma arginine deiminase in Escherichia coli and its efficient renaturation as an anti-tumor enzyme. J Biotechnol. 1994; 36: 145155.
  • 35
    Sasaki T, Shintani M, Kihara K. Inhibition of growth of mammalian cell cultures by extracts of arginine-utilizing Mcyoplasmads. In Vitro. 1984; 20: 369375.
  • 36
    van Diggelen OP, Shin S-i, Phillips DM. Reduction in cellular tumorigenicity after Mcyoplasmad infection and elimination of Mcyoplasmad from infected cultures by passage in nude mice. Cancer Res. 1977; 37: 26802687.